U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07066839) titled 'Chrysin Bioavailability and Safety' on July 04.
Brief Summary: This study seeks to evaluate and compare the pharmacokinetics of a micellar chrysin formulation (LipoMicel Chrysin) with that of a non-micellar chrysin formulation as well as a standard/unformulated chrysin supplement. The study also seeks to determine the short-term effects and safety of daily oral supplementation of LipoMicel Chrysin in healthy adult volunteers over a 30-day study period.
Study Start Date: Dec. 05, 2024
Study Type: INTERVENTIONAL
Condition:
Bioavailability and Pharmacokinetics
Safety After Oral Intake
Intervention:
DIETARY_SUPPLEMENT: LipoMicel C...